Benztropine Mesylate Injection
Fresenius Kabi USA, LLC
Open FDA's page for this record- Discontinued date
- 01/27/2026
- Update type
- New
- Initial posting date
- 01/27/2026
- Package NDC
- 63323-970-02
- Generic name
- Benztropine Mesylate Injection
- Contact info
- 888-386-1300
- Related info
- Discontinuation of the manufacture of the drug
- Update date
- 01/27/2026
- Dosage form
- Injection
- Presentation
- Benztropine Mesylate, Injection, 1 mg/1 mL (NDC 63323-970-02)
- Company name
- Fresenius Kabi USA, LLC
- Status
- To Be Discontinued
- Therapeutic category
- Neurology
- Harmonized identifiers (openFDA)
- Application number
- ANDA090233
- Brand name
- BENZTROPINE MESYLATE
- Generic name
- BENZTROPINE MESYLATE
- Manufacturer name
- Fresenius Kabi USA, LLC
- Product NDC
- 63323-970
- Product type
- HUMAN PRESCRIPTION DRUG
- Route
- INTRAMUSCULAR, INTRAVENOUS
- Substance name
- BENZTROPINE MESYLATE
- RxCUI
- 885205
- SPL ID
- 11222231-55b1-48ee-a8f8-3385f1a2eb36
- SPL set ID
- b03bd28e-3b44-41e4-9a7e-28b9d7975245
- Package NDC
- 63323-970-02
- UNII
- WMJ8TL7510